Your browser doesn't support javascript.
loading
Costs of Severe to Profound Hearing Loss & Cost Savings of Cochlear Implants.
Cejas, Ivette; Barker, David H; Petruzzello, Esteban; Sarangoulis, Christina M; Quittner, Alexandra L.
Afiliación
  • Cejas I; Department of Otolaryngology, University of Miami, Miami, Florida, U.S.A.
  • Barker DH; Department of Psychiatry, Rhode Island Hospital, Providence, Rhode Island, U.S.A.
  • Petruzzello E; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island, U.S.A.
  • Sarangoulis CM; Economics, Miami Herbert Business School, Coral Gables, Florida, U.S.A.
  • Quittner AL; Department of Otolaryngology, University of Miami, Miami, Florida, U.S.A.
Laryngoscope ; 2024 May 14.
Article en En | MEDLINE | ID: mdl-38742597
ABSTRACT

OBJECTIVE:

To estimate costs of severe to profound hearing loss, including costs and cost-savings associated with cochlear implantation.

METHODS:

Data was obtained from the National Health Interview Survey, the National Health and Nutrition Examination Survey and national Medicare rates. We used continuous time state transition models with individual patient simulations to estimate the costs of severe to profound hearing loss (SPHL) across the lifespan. The model included four states, normal hearing, severe to profound hearing loss, cochlear implantation, and death.

RESULTS:

The estimated lifetime cost of an individual born with SPHL is $489,274 [377,518; 616,519]. Costs are lower for those who received a cochlear implant before 18 months of age $390,931 [311,976; 471,475], compared to those who are not implanted $608,167 [442,544; 791,719]. For individuals with a later onset of hearing loss (60 years old) lifetime costs were $154,536 [7,093; 302,936]. The annual societal costs for the US population were estimated to be $37 [8; 187] billion.

CONCLUSIONS:

SPHL is a costly condition, with the primary driver being lost productivity. Medical costs were higher for cochlear implantation, however, the higher income earnings offset the higher medical costs. Overall, early implantation substantially reduced lifetime costs. Access to hearing health care and technology is critical given the documented benefits for language, education, and quality of life. Government and insurance policies should be modified to allow for equal access and coverage for hearing technology, which will ultimately reduce lifetime and societal costs. LEVELS OF EVIDENCE N/A The current study used existing nationally representative datasets. Thus, these levels of evidence do not apply. Laryngoscope, 2024.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Laryngoscope Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Laryngoscope Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos